

Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-05-03 | 2023-03 | -0.3 | -0.28 | 0.02 | 6.67% |
2023-02-21 | 2022-12 | -0.19 | -0.38 | -0.19 | -100.00% |
2022-11-01 | 2022-09 | -0.32 | -0.23 | 0.09 | 28.13% |
2022-08-04 | 2022-06 | -0.36 | -0.32 | 0.04 | 11.11% |
2022-05-05 | 2022-03 | -0.39 | -0.4 | -0.01 | -2.56% |
2022-02-23 | 2021-12 | -0.31 | -0.4 | -0.09 | -29.03% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-05-04 | RBC Capital | Upgrade | Sector Perform | |
2023-05-04 | Needham | Upgrade | Buy | |
2023-04-20 | Evercore ISI Group | Upgrade | Outperform | |
2023-04-20 | Needham | Upgrade | Buy | |
2023-03-14 | RBC Capital | Upgrade | Sector Perform | |
2023-02-22 | JMP Securities | Upgrade | Market Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-12-18 | BARNES ALANE P | Officer | 232.77K | Stock Award(Grant) |
2022-12-18 | GAYER CHARLES K | Officer | 245.61K | Stock Award(Grant) |
2023-05-30 | HEGGIE THERESA | Director | 32.37K | Stock Award(Grant) |
2023-02-27 | INGRAM ROBERT ALEXANDER | Director | 100.20K | Stock Award(Grant) |
2022-12-18 | JONES MICHAEL L. | Officer | 16.65K | Stock Award(Grant) |
2023-01-30 | LEE KENNETH B. | Director | 52.12K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-03-30 | Blackrock Inc. | 14.82M | 130.61M | 7.85% |
2023-03-30 | Vanguard Group, Inc. (The) | 14.83M | 130.62M | 7.85% |
2023-03-30 | Baker Brothers Advisors, LLC | 12.71M | 111.98M | 6.73% |
2023-03-30 | State Street Corporation | 11.39M | 100.34M | 6.03% |
2023-03-30 | Avoro Capital Advisors LLC | 10.42M | 91.80M | 5.52% |
2023-03-30 | Pictet Asset Management SA | 5.62M | 49.50M | 2.97% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-02-27 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 6.52M | 57.43M | 3.46% |
2022-12-30 | Vanguard Total Stock Market Index Fund | 5.65M | 49.79M | 3.00% |
2023-02-27 | iShares Russell 2000 ETF | 4.10M | 36.12M | 2.18% |
2023-02-27 | Fidelity Select Portfolios - Biotechnology | 2.69M | 23.73M | 1.43% |
2022-12-30 | Vanguard Extended Market Index Fund | 2.52M | 22.19M | 1.34% |
2022-12-30 | Vanguard Small-Cap Index Fund | 2.40M | 21.16M | 1.27% |
Dividend | Date |
---|---|
0 | 2014-06-11 |
0 | 2014-06-05 |
0 | 2014-05-20 |
0 | 2014-05-16 |
0 | 2014-04-02 |
-
$BCRX 15 SHARES Pre mkt.
-
$BCRX Marango give it up buddy spew your loser garbage somewhere else move on!
-
$BCRX Glad I’ve got a $1.92 avg.
-
$BCRX this could be the next CCXI….then mabe NOT!
-
$BCRX News flash we are up $3.03 from 3/15/2018 wow!
-
$BCRX I mean sell some more.
-
$BCRX 9 scripts …1.25 scripts per continent Boy we are tearing um up better buy some more shares
-
$BCRX Maphere folded his tent and moved to CLSD a few weeks back
-
$BCRX It’s ashamed this board is turning into a nursery play room
-
$BCRX Another day of baby Joey
-
$BCRX @Joey Go away you lost. Take it like a man move on get off the lot see u later!
-
$BCRX Man oh man holding since 2019 through ups and downs kept the faith but it’s getting hard we are sitting here on a day we should be running and the shorts are sticking it to us what to do
-
$BCRX Let’s get um Horned Frogs
-
-
$BCRX Well we’ve got us a new cry baby
-
-
$BCRX 2023 Watch for headers and lifts and tack on the shifts same as 2022
-
$BCRX Alright it’s time to head back north and close at the HOD
-
$BCRX Bzzzz Bzzzz
-
Considering BioCryst Pharmaceuticals Inc. (BCRX) as a potential ...
news.google.com •